证券记录 · 已归档季度
DYN
Dyne Therapeutics, Inc. · Healthcare · Biotechnology
10被追踪持有人
-2Δ持有人
10.58M持有股份
$380.14M报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -16.7% ·
股份流向 -19.4% ·
净新建仓位 -20.0%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +1 | 73.72M | $1.63B | +7 | −5 |
| Q1 2026 | 87 | -4 | 78.51M | $1.42B | +7 | −12 |
| Q4 2025 | 92 | 0 | 87.58M | $1.71B | +2 | −1 |
| Q3 2025 | 18 | +1 | 57.06M | $721.88M | +1 | −1 |
| Q2 2025 | 15 | +2 | 34.50M | $328.45M | +2 | — |
| Q1 2025 | 10 | -1 | 12.46M | $130.33M | +1 | −2 |
| Q4 2024 | 11 | 0 | 14.93M | $351.71M | +1 | −1 |
| Q3 2024 | 10 | -2 | 10.58M | $380.14M | +1 | −3 |
| Q2 2024 | 12 | — | 13.13M | $463.42M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 2.94M | -31.9% | $105.58M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.64M | +11.4% | $94.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.64M | +11.4% | $94.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 2.40M | -27.8% | $86.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.86M | +4.8% | $66.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 1.86M | +4.8% | $66.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 432.33K | +303.7% | $15.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 102.48K | -71.3% | $3.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 89.20K | +950.0% | $3.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 89.20K | +950.0% | $3.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 89.20K | +950.0% | $3.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 73.04K | -17.4% | $2.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 41.66K | -81.6% | $1.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 41.66K | -81.6% | $1.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 41.66K | -81.6% | $1.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 41.66K | -81.6% | $1.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 5.99K | 新增 | $215,197 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $215,197 | 0.0% |
已清仓
| Marshall Wace | $9.65M | 曾为 0.0% |
| Two Sigma Investments | $5.62M | 曾为 0.0% |
| Renaissance Technologies | $4.45M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 226 持有人, 184.59M 股份, $2.74B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 14
Rhodes Jason P
Director · 1.36M 股 · $33.99M
Aug 14
Rhodes Jason P
Director · 478.38K 股 · $11.96M
Aug 14
Rhodes Jason P
Director · 322.46K 股 · $8.06M
Aug 13
Rhodes Jason P
Director · 63.64K 股 · $1.67M
Aug 13
Lucera Erick
Officer · 1.80K 股 · $47,225
Aug 13
Kerr Douglas
Officer · 1.56K 股 · $40,892
Aug 13
Cox John
Officer, Director · 4.99K 股 · $131,032
Aug 13
Friedl-Naderer Johanna
Officer · 226 股 · $5,939
Aug 13
Rhodes Jason P
Director · 268.35K 股 · $7.03M
Aug 13
Rhodes Jason P
Director · 94.42K 股 · $2.47M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Janus Henderson Group Ltd.
Aug 13
SC 13G/A — Atlas Venture Fund XI, L.P.
Aug 06
SC 13G/A — FMR LLC
Jul 28
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据